ATE128865T1 - Verwendung von l-deprenyl zur herstellung eines arzneimittels zur behandlung der cushing's- krankheit. - Google Patents
Verwendung von l-deprenyl zur herstellung eines arzneimittels zur behandlung der cushing's- krankheit.Info
- Publication number
- ATE128865T1 ATE128865T1 AT93300476T AT93300476T ATE128865T1 AT E128865 T1 ATE128865 T1 AT E128865T1 AT 93300476 T AT93300476 T AT 93300476T AT 93300476 T AT93300476 T AT 93300476T AT E128865 T1 ATE128865 T1 AT E128865T1
- Authority
- AT
- Austria
- Prior art keywords
- deprenyl
- disease
- cushing
- treatment
- production
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/858,702 US5192808A (en) | 1990-08-31 | 1992-03-27 | Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE128865T1 true ATE128865T1 (de) | 1995-10-15 |
Family
ID=25328952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93300476T ATE128865T1 (de) | 1992-03-27 | 1993-01-22 | Verwendung von l-deprenyl zur herstellung eines arzneimittels zur behandlung der cushing's- krankheit. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5192808A (de) |
| EP (1) | EP0562705B1 (de) |
| AT (1) | ATE128865T1 (de) |
| DE (1) | DE69300608T2 (de) |
| DK (1) | DK0562705T3 (de) |
| ES (1) | ES2082587T3 (de) |
| GR (1) | GR3018657T3 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2039194C (en) * | 1990-08-31 | 1997-01-28 | Norton W. Milgram | Uses of l-deprenyl and compositions for same |
| US5561163A (en) * | 1990-08-31 | 1996-10-01 | Deprenyl Animal Health, Inc. | Treating hearing loss with deprenyl |
| US5565495A (en) * | 1990-08-31 | 1996-10-15 | Deprenyl Animal Health, Inc. | Method for survival curve shifting in dogs |
| US5817336A (en) * | 1993-04-02 | 1998-10-06 | Orion-Yhtyma Oy | Composition containing selegiline |
| US5547995B1 (en) * | 1993-05-04 | 1998-01-27 | Sanofi Elf | Use of selegiline in veterinary medicine |
| FR2704756B1 (fr) * | 1993-05-04 | 1995-07-28 | Sanofi Elf | Utilisation de la sélégiline en médecine vétérinaire. |
| DE4428444A1 (de) * | 1994-08-11 | 1996-02-15 | Dresden Arzneimittel | Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen |
| NZ309980A (en) | 1995-06-07 | 2001-06-29 | Noven Pharma | Transdermal composition containing a blend of one or more polymers, one or more drugs that has a low molecular weight and is liquid at room temperature |
| US6316022B1 (en) | 1995-06-07 | 2001-11-13 | Noven Pharmaceuticals, Inc. | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| DK0866691T4 (da) * | 1995-11-06 | 2005-06-06 | Somerset Pharmaceuticals Inc | Medikamenter til sublingual og bukkal administration af selegilin |
| US6262111B1 (en) | 1997-05-21 | 2001-07-17 | Sloan-Kettering Institute For Cancer Research | Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| CA2290381A1 (en) | 1997-05-21 | 1998-11-26 | Sloan-Kettering Institute For Cancer Research | Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| JP4757024B2 (ja) * | 2002-11-07 | 2011-08-24 | テクニオン リサーチ アンド ディベラップメント ファウンデイション リミテッド | 神経保護鉄キレート剤及びそれを含む医薬組成物 |
| US8097608B2 (en) * | 2003-11-25 | 2012-01-17 | Technion Research And Development Foundation Ltd. | Methods for treatment of cardiovascular disorders and diseases |
| EP1686973A4 (de) * | 2003-11-25 | 2009-03-25 | Technion Res & Dev Foundation | Zusammensetzungen und verfahren zur behandlung von kardiovaskulären erkrankungen und krankheiten |
| US8263655B2 (en) * | 2005-10-06 | 2012-09-11 | Technion Research And Development Foundation Ltd | Methods for treatment of renal failure |
| DK2531181T3 (da) | 2010-02-03 | 2019-07-15 | Pharma Two B Ltd | Formuleringer af rasagilin med forlænget afgivelse og anvendelser deraf |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA871155A (en) * | 1971-05-18 | Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt | Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation | |
| HU187775B (en) * | 1982-07-14 | 1986-02-28 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu | New process for producing propargile-amines of pharmaceutical activity |
| HU193662B (en) * | 1983-12-20 | 1987-11-30 | Chinoin Gyogyszer Es Vegyeszet | Process for producing synergetic pharmaceutical composition of antidepressive aktivity |
| US4916151A (en) * | 1985-12-05 | 1990-04-10 | Merrell Dow Pharmaceuticals Inc. | Method of treating parkinson's syndrome |
| US4871550A (en) * | 1986-09-05 | 1989-10-03 | Millman Phillip L | Nutrient composition for athletes and method of making and using the same |
| US4861800A (en) * | 1987-08-18 | 1989-08-29 | Buyske Donald A | Method for administering the drug deprenyl so as to minimize the danger of side effects |
-
1992
- 1992-03-27 US US07/858,702 patent/US5192808A/en not_active Expired - Lifetime
-
1993
- 1993-01-22 DK DK93300476.4T patent/DK0562705T3/da active
- 1993-01-22 ES ES93300476T patent/ES2082587T3/es not_active Expired - Lifetime
- 1993-01-22 DE DE69300608T patent/DE69300608T2/de not_active Expired - Fee Related
- 1993-01-22 EP EP93300476A patent/EP0562705B1/de not_active Expired - Lifetime
- 1993-01-22 AT AT93300476T patent/ATE128865T1/de not_active IP Right Cessation
-
1996
- 1996-01-11 GR GR960400055T patent/GR3018657T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2082587T3 (es) | 1996-03-16 |
| DK0562705T3 (da) | 1996-02-19 |
| GR3018657T3 (en) | 1996-04-30 |
| DE69300608T2 (de) | 1996-06-05 |
| EP0562705B1 (de) | 1995-10-11 |
| DE69300608D1 (de) | 1995-11-16 |
| US5192808A (en) | 1993-03-09 |
| EP0562705A1 (de) | 1993-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE128865T1 (de) | Verwendung von l-deprenyl zur herstellung eines arzneimittels zur behandlung der cushing's- krankheit. | |
| ATE271874T1 (de) | Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen | |
| DE236684T1 (de) | Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit. | |
| SE9401406D0 (sv) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| ATE206919T1 (de) | Verwendung des wirkstoffs flupirtin zur herstellung eines arzneimittels zur bekämpfung von muskelverspannungen | |
| ATE86478T1 (de) | Pflegemittel, insbesondere zur pflege des gebisses von hunden. | |
| ATE110958T1 (de) | Verwendung von sertralin zur behandlung verfrühter ejakulation. | |
| DE69328186D1 (de) | Zusammensetzung zur behandlung der parkinson-krankheit | |
| ATE137965T1 (de) | Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege | |
| EP0308197A3 (de) | Verfahren zur Stimulierung des Immunsystems | |
| DE3784628D1 (de) | Dermale behandlung von wurmerkrankungen der katze mit praziquantel. | |
| DE69733169D1 (de) | Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs | |
| DE69007065D1 (de) | Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten. | |
| ES2110550T3 (es) | Tratamiento de la carne o del pescado. | |
| DE59304087D1 (de) | Placentaextrakt und Verfahren zu seiner Herstellung | |
| ATE204476T1 (de) | Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem | |
| US5547995B1 (en) | Use of selegiline in veterinary medicine | |
| DE69424415D1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
| DE69300037D1 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
| DE69124382D1 (de) | Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände | |
| ATE192336T1 (de) | Verwendung von bifemelan zur herstellung eines arzneimittels zur behandlung der hyperkinesie | |
| DE3777709D1 (de) | Verwendung von 3'azido-3'deoxythymidin zur herstellung eines arzneimittels zur behandlung von gardiasis. | |
| FR2708202B1 (fr) | Implant biocompatible pour l'expression chez l'homme ou chez l'animal de substances déterminées. | |
| IT8802917A0 (it) | L'impiego del prodotto risultante metodo per il trattamento chimico come fertilizzante. delle deiezioni animali e per |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |